Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients (NAPLESIII)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Carlo Briguori, Clinica Mediterranea
ClinicalTrials.gov Identifier:
NCT01465503
First received: November 1, 2011
Last updated: April 6, 2014
Last verified: April 2014